Newsfeed : Safety of Indian AIDS Meds Challenged in U.S. Probe

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » July 2008

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

July 15, 2008

Safety of Indian AIDS Meds Challenged in U.S. Probe

India’s largest pharmaceutical company faces a U.S. investigation into allegations that the company made weak or adulterated HIV drugs given to thousands of AIDS patients in Africa and tried to cover it up, The Wall Street Journal reports (online.wsj.com 7/15).

The company, Ranbaxy Inc., received millions of dollars through American contracts under the President’s Emergency Plan for AIDS Relief (PEPFAR). Investigators from the Justice Department and the Food and Drug Administration said some of the drugs were poorly made, unstable or impotent. Ranbaxy fabricated documents to cover up the substandard products, court fillings said.

Ranbaxy said in a filing in a Maryland federal court that it was cooperating with investigators and will turn over disputed documents. According to the article, company stock shares fell more than 10 percent Monday in London after it issued a statement acknowledging the U.S. probe.

In the filing, Ranbaxy acknowledged “some serious allegations concerning compliance with U.S. law,” but the filing said that, “except for issues that have been fully aired with the government, Ranbaxy knows of no evidence to support these allegations.” A company spokesman, Chuck Caprariello, declined to elaborate.

Search: India, Ranbaxy


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    charliehunter
    San Francisco
    California


    soy_Ric
    Rochester
    New York


    Sexynyrican
    Brooklyn
    New York


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.